China may spend US$1.5 trillion on outbound acquisitions, Linklaters says

China may spend US$1.5 trillion on outbound acquisitions, Linklaters says

Chinese acquirers will spend US$1.5 trillion buying companies and investing overseas in the next decade, 70 per cent more than the previous 10 years, even as regulators at home and abroad block deals, Linklaters LLP said in a report Tuesday...

Read more
India May Reject Fosun’s $1.3 Billion Acquisition of Gland Pharma

India May Reject Fosun’s $1.3 Billion Acquisition of Gland Pharma

Shanghai FosunPharma’s $1.3 billion acquisition of a majority stake in India’s Gland Pharma is in trouble. It may be rejected by India, not because of the deal itself, but because China and India are in a military stand-off over a...

Read more
China Focus: More M&As expected in China’s LED industry

China Focus: More M&As expected in China’s LED industry

China’s LED industry will accelerate mergers and acquisitions (M&A) in a plan seeking to foster world-class brands. In a development plan jointly released by 13 government agencies, China aims to achieve breakthroughs in key...

Read more
Exclusive: China eyes merger of metals giants Minmetals and China National Gold – sources

Exclusive: China eyes merger of metals giants Minmetals and China National Gold – sources

China is considering a merger between China Minmetals Corp, one of the country’s largest miners and metals traders, and China National Gold Group, as Beijing pushes consolidation of its state-run firms, sources with knowledge of the matter...

Read more
Eldorado finishes Integra Gold acquisition, expands operations in Canada

Eldorado finishes Integra Gold acquisition, expands operations in Canada

Canada’s miner Eldorado Gold (TSX:ELD) (NYSE:EGO) has taken over Integra Gold (TSX-V:ICG) in a move that helps it strengthen its position in the home country, particularly around the gold-rich Eastern Abitibi region, in Quebec. The deal, worth...

Read more
Uranium Energy acquires Paraguay-based titanium project

Uranium Energy acquires Paraguay-based titanium project

Shares in junior miner and exploration firm Uranium Energy Corp. (NYSE MKT: UEC) received a boost Monday after it announced it had exercised a previously disclosed option to acquire Paraguay’s CIC Resources. The deal gives the Texas-based company...

Read more
Altrad Investment to buy UK oil services firm Cape for 332.2 million pounds

Altrad Investment to buy UK oil services firm Cape for 332.2 million pounds

French construction equipment maker Altrad Investment Authority said on Friday it agreed to buy UK oil services company Cape Plc for about 332.2 million pounds ($430.3 million) in cash. The offer for 265 pence per Cape share represents a premium...

Read more
Paramount Resources to buy Apache subsidiary for C$459.5 million

Paramount Resources to buy Apache subsidiary for C$459.5 million

Canadian oil producer Paramount Resources Ltd (POU.TO) said on Thursday that it would buy the Canadian subsidiary of U.S. oil and gas firm Apache Corp (APA.N) for C$459.5 million ($353.7 million USD). The Calgary-based energy company plans to buy...

Read more
AGIC Capital To Acquire US Pharmaceutical Firm Ritedose For Asian Expansion

AGIC Capital To Acquire US Pharmaceutical Firm Ritedose For Asian Expansion

An investor consortium led by AGIC Capital, an Asia-Europe cross-border growth equity firm founded by former Deutsche Bank executive Henry Cai, has agreed to acquire U.S. pharmaceutical firm the Ritedose Corporation from private equity firm...

Read more
EQT’s purchase of Rice Energy just created a new energy powerhouse

EQT’s purchase of Rice Energy just created a new energy powerhouse

Pittsburgh-based EQT Corp. is poised to become the largest producer of natural gas in the United States after announcing it will acquire fellow shale driller Rice Energy. EQT announced on Monday it will buy all of Rice Energy’s shares in a...

Read more
Chinese investors to buy SciClone Pharmaceuticals, firm valued at $605m

Chinese investors to buy SciClone Pharmaceuticals, firm valued at $605m

A consortium of Chinese investors has agreed to acquire SciClone Pharmaceuticals, the US-based, China-focused specialty pharmaceutical firm, for $11.18 per share in cash. The deal, which values the pharma company at about $605 million, will be...

Read more
Do NOT follow this link or you will be banned from the site!